Foretinib
| CAS No. | 849217-64-7 |
|---|---|
| MDL No. | MFCD16038048 |
| MF | C34H34F2N4O6 |
| MW | 632.70 |
| InChI Key | CXQHYVUVSFXTMY-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Foretinib is a quinoline substituted at positions 4, 6, and 7 with 2-fluoro-4-[({1-[(4-fluorophenyl)carbamoyl]cyclopropyl}carbonyl)amino]phenoxy, methoxy, and 3-(morpholin-4-yl)propoxy groups, respectively. It is a multi-kinase inhibitor with activity as a c-Met tyrosine kinase inhibitor, vascular endothelial growth factor receptor antagonist, antineoplastic agent, and apoptosis inducer. It belongs to the classes of aromatic ethers, morpholines, quinolines, monofluorobenzenes, cyclopropanes, and dicarboxylic acid diamides.
| CAS No. | 849217-64-7 |
|---|---|
| Product Name | Foretinib |
Biological Targets
MET·PDGFRB·PDGFRA·KIT·TEK·
Associated Conditions
breast cancer·hepatocellular carcinoma·head and neck neoplasia·lung cancer·neoplasm·
* The information provided here is compiled from public sources and is for reference only.
